This year was a better year for short sellers than last year, Jim Chanos said. Here's what he's shorting now.» Read More
In an interview on CNBC, Buffett also criticized Coca-Cola's controversial equity plan, but said Berkshire Hathaway abstained on the shareholder vote.
Apple surged on better-than-expected earnings and a 7:1 stock split. Activist investor Carl Icahn said the company remains "undervalued."
CNBC's Becky Quick discusses Warren Buffett's feelings about the market.
Warren Buffett discusses activist investing and shares his thoughts on David Winters and Bill Ackman.
CNBC's Becky Quick speaks with Warren Buffett about his position in IBM after its disappointing earnings report. I've bought stock this year and have never sold a share, Buffett said.
CNBC's Becky Quick speaks with Warren Buffett about why he abstained in his vote on Coke shareholder equity plan. The package was excessive, he says.
CNBC's Becky Quick speaks with Warren Buffett about why he abstained from voting on Coca-Cola's executive-compensation plan and responds to activist investor David Winters criticism. "We didn't disapprove of management, but we did disapprove of the plan," Buffett said.
Discussing how the market is trading during earnings season, with and Abigail Doolittle, Peak Theories; Dennis Gartman, The Gartman Letter; Jack Bouroudjian, Index Financial Partners; and CNBC's Rick Santelli.
Former Minnesota Governor Jesse Ventura makes the case that CEO pay is "way out of line" and that we should stop cheapening the idea of physical labor. "Shark Tank" investor Kevin O'Leary and CNBC's Kate Kelly weigh in.
A recent report shows that over 1,000 IRS employees with "federal tax compliance problems" received more than $1 million in bonuses. CNBC's Eamon Javers reports.
Matt Levatich, Harley-Davidson president and COO, discusses international opportunities and looks at its distribution channel as a strength for the motorcycle maker.
Terry Duffy, CME Group executive chairman, doesn't believe the market is "rigged" and looks at the wealth and opportunities it creates for investors and companies. Michael Gayed, The Inflation Rotation Fund, and CNBC's Sharon Epperson weigh in on the high-frequency trading controversy.
Providing insight on Bill Ackman and Valeant's proposed takeover of Allergan, with former SEC chairman Harvey Pitt and CNBC's Kate Kelly.
And it all has to do with how earnings are valued, the founder of the Vanguard group told CNBC.
CEOs and physical laborers should be closer in pay, former Minnesota Gov. Jesse Ventura told CNBC on Tuesday.
Providing instant analysis to Gilead and Amgen's quarterly numbers, with David Nelson, Belpointe Asset Management, and CNBC's Sharon Epperson and Kate Kelly.
Gilead is reporting Q1 EPS of $1.48 adj. on revenues of $5.00 billion, with CNBC's Meg Tirrell.
"Shark Tank" investor Kevin O'Leary discusses recent mergers between pharmaceutical companies.
Amgen is reporting Q1 EPS of $1.87 ex-items on revenues of $4.52 billion, with CNBC's Meg Tirrell.
AT&T is reporting Q1 EPS of $0.71 on revenue of $32.5 billion, with CNBC's Dominic Chu.